WO2017195951A1 - Supplément cosmétique et nutritionnel utilisant un aptamère et procédé de production associé - Google Patents

Supplément cosmétique et nutritionnel utilisant un aptamère et procédé de production associé Download PDF

Info

Publication number
WO2017195951A1
WO2017195951A1 PCT/KR2016/011741 KR2016011741W WO2017195951A1 WO 2017195951 A1 WO2017195951 A1 WO 2017195951A1 KR 2016011741 W KR2016011741 W KR 2016011741W WO 2017195951 A1 WO2017195951 A1 WO 2017195951A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
aptamer
antioxidant
extract
present
Prior art date
Application number
PCT/KR2016/011741
Other languages
English (en)
Korean (ko)
Inventor
손인식
Original Assignee
주식회사 넥스모스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 넥스모스 filed Critical 주식회사 넥스모스
Priority to PCT/KR2017/004823 priority Critical patent/WO2017196077A1/fr
Publication of WO2017195951A1 publication Critical patent/WO2017195951A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides

Definitions

  • the present invention relates to cosmetics and nutritional supplements using aptamers and to a method of manufacturing the same, and more particularly, to cosmetics and nutritional supplements using long-term maintenance and antioxidant properties of antioxidants such as reduced vitamin C by aptamers. Is to apply.
  • ROS active oxygen species
  • Antioxidants can be divided into those that exist naturally in the human body and those that are administered externally.
  • Antioxidants that are naturally present in the human body include enzymes such as superoxide dismutase (SOD), glutathione, peroxidase and catalase. phytochemicals such as kaempferol, catechin and genistein; Vitamin E, vitamin C and beta carotene; And minerals such as selenium.
  • SOD superoxide dismutase
  • glutathione glutathione
  • peroxidase and catalase
  • phytochemicals such as kaempferol, catechin and genistein
  • Vitamin E Vitamin C and beta carotene
  • minerals such as selenium.
  • Vitamin C L-ascorbic acid, ascorbate
  • Vitamin C deficiency will cause diseases such as scurvy (Scurvy).
  • Vitamin C in animals is an important factor in preventing wound healing and capillary bleeding, and is an important antioxidant in the body along with Vitamin A and Vitamin E.
  • UVA UVA
  • UVB ultraviolet B
  • pollutants pollutants
  • stress smoking, drinking, fatty foods, etc.
  • cells may age or die.
  • these substances reduce or degenerate the production of collagen and elastin, causing the skin to lose elasticity and wrinkles.
  • antioxidants such as vitamin A, C, E
  • the present invention has been made in view of the above necessity, and an object of the present invention is to provide a substance which acts as an antioxidant for antioxidant substances.
  • the present invention provides an aptamer for preventing oxidation of an antioxidant substance.
  • the present invention also provides an aptamer and an antioxidant complex obtained by combining an antioxidant with the aptamer of the present invention.
  • the antioxidant is preferably a substance selected from the group consisting of vitamin C, vitamin A, retinol, vitamin E, astaxanthin, resveratinol, polyphenols, coenzyme Q10, peptides and oils.
  • the antioxidant is not limited thereto.
  • the present invention provides a cosmetic composition comprising the aptamer and antioxidant complex of the present invention as an active ingredient.
  • the cosmetic composition preferably further comprises one or more of collagen, elastin, hyaluronic acid, and a peptide, but is not limited thereto.
  • the cosmetic composition is to release the bound antioxidant (eg, vitamin C) when the structure of the aptamer changes according to the ultraviolet irradiation of the skin, or ATP according to the change in the temperature or acidity of the skin It is preferable to release vitamin C as the structure of the aptamer which binds thereto when the amount is changed, but is not limited thereto.
  • the bound antioxidant eg, vitamin C
  • the cosmetic composition of the present invention can use any raw material used in cosmetics regardless of any kind of extracts, active substances.
  • green tea extract, licorice extract, medicinal extract, lettuce extract, golden extract, pueraria extract, red ginseng extract and apricot extract oil extract, orange extract, lemon extract, bamboo extract guava extract Rosemary Extract Cornus Extract, Ganoderma Lucidum Extract Ginkgo Extract Seoxiok-Yuksan Extract Consonant Extract, Moisturizing Chinese Quince Extract, White Lotus Extract, Paprika Extract, Aloe Extract, Scrubber Extract, Seaweed Extract, Antioxidant Carrot Extract, Soybean Extract, Grapefruit Extract Grape Seed Extract, Portulaca Extract, Caviar to Improve Wrinkles, Pomegranate, Ginseng Extract, Peach Extract for Skin Regeneration, Cheongung Extract, Centella asiatic Extract, Chamomile Extract, Licorice Extract, Ginseng Extract, Angelica Extract, Acne Good peppermint extract, triticale extract, eosungcho extract , Pe
  • the present invention provides a nutritional supplement composition comprising the aptamer and antioxidant complex of the present invention as an active ingredient.
  • vitamins for the nutritional supplements of the present invention include vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, vitamin B 6, vitamin B 12, thiamine, riboflavin, biotin, folic acid, niacin, pantothenic acid, mixtures thereof, and the like. to be.
  • suitable mineral nutrients to be included in the dietary supplement composition are selected from sodium, potassium, calcium, magnesium, phosphorus, sulfur, chlorine, iron, copper, iodine, zinc, selenium, manganese, chromium, molybdenum, fluorine, cobalt, and compounds thereof They hold more than one element.
  • herbs can also be used as nutritional supplements.
  • herbs are selected from those having various medicinal or dietary supplement properties.
  • herbs are aromatic plants or parts of plants that can be used for medicinal or flavoring purposes.
  • the present invention provides a method for binding an aptamer to an antioxidant to maintain the reduced state of the antioxidant and prevent oxidation.
  • the present invention like Vitamin C, vitamin A (Retinol), Vitamin E, Astaxanthin, Resveratinol, Polyphenol, Coenzyme Q10, Peptide, Oil, etc. Can be used to manufacture. This prevents the oxidation (corrosion) of the materials to ensure that they maintain the maximum effect they require. In addition, by releasing it under a target condition through apta-sensing, the effect can be increased as much as possible.
  • Aptamer is a method of detecting a specific substance by using the three-dimensional structure of single strand DNA or RNA, which is similar to an antigen-antibody reaction, but has a much smaller substance, and can be controlled in various ways. This is an easy advantage. In addition, unlike antibodies, it is possible to synthesize aptamers that bind to very small chemicals (vitamins) and the like.
  • Vitamin C is a water-soluble six carbon compound, which includes the 3-, 4- and 3-hydrocarbons of the furan ring and the semidehydroascorbic acid and dehydroascorbic acid, which are oxidized in the reduced form and biparticulate, respectively.
  • Vitamin C which is combined with aptamers and maintains a reduced state, may be used in skin care compositions and nutritional supplements of various types of cream or hydrogel types including collagen, elastin, hyaluronic acid and peptides.
  • the present invention also includes a method of slowly releasing Vitamin C according to various conditions of the skin (Aptasensing) through aptamers that react differently depending on the condition of the skin or external stimuli (eg ultraviolet rays or the temperature or acidity of the skin). For example, when the structure of the aptamer is changed by UV irradiation of the skin, the bound antioxidant (e.g., vitamin C) is released or the structure of the aptamer that binds when the amount of ATP changes according to the temperature or acidity of the skin is changed. And a method of releasing Vitamin C as a substitute.
  • aptamers that react differently depending on the condition of the skin or external stimuli (eg ultraviolet rays or the temperature or acidity of the skin). For example, when the structure of the aptamer is changed by UV irradiation of the skin, the bound antioxidant (e.g., vitamin C) is released or the structure of the aptamer that binds when the amount of ATP changes according to the temperature or
  • the aptamer of the present invention has an antioxidant effect of an antioxidant substance such as vitamin C, and the complex of the aptamer and antioxidant of the present invention may be, for example, contained in Vitamin C (ascorbic acid).
  • Vitamin C ascorbic acid
  • Aptamers that selectively bind to maintain the reduced state of Vitamin C to maintain its antioxidant function for a long time can be used in functional cosmetics and oral dietary supplements of various formulations.
  • RNA or DNA RNA
  • Figures 2 to 4 show that the three aptamers of the present invention prevent vitamin C oxidation by hydrogen peroxide solution
  • 5 to 10 are graphs of dissociation constants (KD) for AA (ascorbic acid) and DHA (dehydroascorbic acid) of the aptamer of the present invention.
  • Example 1 bound to reduced vitamin C Aptamer Military building
  • SELEX systematic evolution of ligands by exponential enrichment
  • aptamers were selected and subjected to the anti-oxidation experiment of vitamin C. After heating the aptamer dissolved in the annealing buffer to 95 o C and slowly lowering the temperature to room temperature, the secondary structure of the aptamer is mixed. The reaction was carried out for about 30 minutes. After oxidizing conditions by adding hydrogen peroxide solution, oxidation of L-ascorbic acid was measured by adding OPDA (o-phenylenediamine) as a fluorescent dye. DHA, the oxide of L-ascorbic acid, can be quantitatively analyzed by measuring the amount of fluorescence from DHA-OPDA produced by reaction with OPDA. Under the above conditions, the amount of fluorescence of DHA-OPDA was measured every 34 seconds for 25 minutes.
  • OPDA o-phenylenediamine
  • Example 3 of the present invention Aptamer ascorbic acid (AA) and dehydroascorbic acid ( DHA Steady-state solution dissociation constant (KD)
  • Dissociation constants were determined using microscale thermophoresis (MST).
  • This example includes the MST data and the calculated KD for the three aptamers in the assay buffer for both targets.
  • All reagents containing ascorbic acid and dehydroascorbic acid were purchased from Sigma-Aldrich (St. Louis, MO) and deionized water was treated with Chelex-100 resin for 1 hour to remove accidental metals prior to buffer preparation. After Chelex treatment, the water was sprayed with nitrogen gas for 10 minutes to minimize oxygen and then sealed and stored. This water was used for all aqueous solutions.
  • Final buffer is 50 mM sodium acetate, pH 5.5, 1 mM MgCl 2, and 0.05% Tween-20, both AA and DHA were 153 pM (final) at e5 uM in buffer (for aptamers # 10 &# 12) Or at 1: 1 passage dilution at 1.53 nM (final) (Aptamer # 8) at 50 uM.
  • the final concentration of each Cy5-conjugated aptamer is 20 nM.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un supplément cosmétique et nutritionnel utilisant un aptamère, ainsi qu'un procédé de production associé. Plus particulièrement, l'aptamère selon l'invention a pour effet de prévenir l'oxydation d'un antioxydant, tel que la vitamine C. Le composite d'un aptamère et d'un antioxydant selon l'invention utilise un aptamère se liant de façon sélective à la vitamine C (acide ascorbique) par exemple, de sorte à préserver l'état réduit de la vitamine C et à préserver ainsi sa fonction d'anti-oxydation pendant une longue durée, et il peut donc être utilisé dans des cosmétiques fonctionnels de diverses formulations, dans des suppléments nutritionnels oraux (compléments alimentaires) et analogues.
PCT/KR2016/011741 2016-05-12 2016-10-19 Supplément cosmétique et nutritionnel utilisant un aptamère et procédé de production associé WO2017195951A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/KR2017/004823 WO2017196077A1 (fr) 2016-05-12 2017-05-10 Additif cosmétique et nutritionnel utilisant un aptamère et procédé pour le produire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2016-0058022 2016-05-12
KR20160058022 2016-05-12

Publications (1)

Publication Number Publication Date
WO2017195951A1 true WO2017195951A1 (fr) 2017-11-16

Family

ID=60266544

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/KR2016/011741 WO2017195951A1 (fr) 2016-05-12 2016-10-19 Supplément cosmétique et nutritionnel utilisant un aptamère et procédé de production associé
PCT/KR2017/004823 WO2017196077A1 (fr) 2016-05-12 2017-05-10 Additif cosmétique et nutritionnel utilisant un aptamère et procédé pour le produire

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/004823 WO2017196077A1 (fr) 2016-05-12 2017-05-10 Additif cosmétique et nutritionnel utilisant un aptamère et procédé pour le produire

Country Status (1)

Country Link
WO (2) WO2017195951A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020096296A1 (fr) * 2018-11-06 2020-05-14 주식회사 넥스모스 Procédé pour empêcher l'oxydation de polyphenol à l'aide d'un aptamère, matériau correspondant et utilisation correspondante
CN113164442A (zh) * 2018-10-25 2021-07-23 (株)纳斯摩仕 包含Aptamin-C作为有效成分的用于改善及治疗动物的脱毛、毛发损伤、皮肤疾病的组合物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108543079B (zh) * 2018-05-22 2019-12-24 广东药科大学 一种虾青素-胶原蛋白耦合物及其制备方法和应用
WO2020096240A1 (fr) * 2018-11-06 2020-05-14 주식회사 넥스모스 Aptamère d'adn se liant de manière spécifique au glutathion, et utilisation associée
WO2020222506A1 (fr) * 2019-05-02 2020-11-05 주식회사 넥스모스 Composition orale comprenant un aptamère en tant que principe actif

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235721B1 (en) * 1999-02-17 2001-05-22 Natreon Inc. Stabilization of vitamin C
US20070112064A1 (en) * 2003-07-24 2007-05-17 Lyles Mark B Nucleic acid antioxidant compositions, methods for obtaining such compositions and formulations thereof
WO2009031788A1 (fr) * 2007-09-04 2009-03-12 Cotde, Ltd. Composition cosmétique comprenant de la vitamine c
KR20120043167A (ko) * 2009-04-09 2012-05-03 시므라이즈 아게 피부 자극-완화제로서 트랜스-텔트-부틸 사이클로헥사놀을 포함하는 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235721B1 (en) * 1999-02-17 2001-05-22 Natreon Inc. Stabilization of vitamin C
US20070112064A1 (en) * 2003-07-24 2007-05-17 Lyles Mark B Nucleic acid antioxidant compositions, methods for obtaining such compositions and formulations thereof
WO2009031788A1 (fr) * 2007-09-04 2009-03-12 Cotde, Ltd. Composition cosmétique comprenant de la vitamine c
KR20120043167A (ko) * 2009-04-09 2012-05-03 시므라이즈 아게 피부 자극-완화제로서 트랜스-텔트-부틸 사이클로헥사놀을 포함하는 조성물

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HE, XIAOXIAO ET AL.: "ATP-Responsive Controlled Release System Using Aptamer -Functionalized Mesoporous Silica Nanoparticles", LANGMUIR, vol. 28, no. 35, 23 August 2012 (2012-08-23), pages 12909 - 12915, XP055106436 *
KRYLOVA, SVETLANA M. ET AL.: "Mechanistic Studies on the Application of DNA Aptamers as Inhibitors of 2-oxoglutarate-dependent Oxygenases", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 7, 3 March 2012 (2012-03-03), pages 3546 - 3552, XP055414197 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164442A (zh) * 2018-10-25 2021-07-23 (株)纳斯摩仕 包含Aptamin-C作为有效成分的用于改善及治疗动物的脱毛、毛发损伤、皮肤疾病的组合物
WO2020096296A1 (fr) * 2018-11-06 2020-05-14 주식회사 넥스모스 Procédé pour empêcher l'oxydation de polyphenol à l'aide d'un aptamère, matériau correspondant et utilisation correspondante
CN113439122A (zh) * 2018-11-06 2021-09-24 (株)纳斯摩仕 利用适配体防止多酚氧化的方法、其物质及其用途

Also Published As

Publication number Publication date
WO2017196077A1 (fr) 2017-11-16

Similar Documents

Publication Publication Date Title
WO2017150891A1 (fr) Procédé d'anti-oxydation pour substance anti-oxydante, et substance et utilisation associées
WO2017196077A1 (fr) Additif cosmétique et nutritionnel utilisant un aptamère et procédé pour le produire
Singh et al. Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health
Nagai et al. Preparation and the functional properties of water extract and alkaline extract of royal jelly
Dartsch Antioxidant potential of selected Spirulina platensis preparations
Surget et al. Marine green macroalgae: A source of natural compounds with mineralogenic and antioxidant activities
ES2810848T3 (es) Microcápsulas que contienen agente activo
KR102436816B1 (ko) 그라비올라 한방 추출물을 포함하는 화장료 조성물
WO2018092968A1 (fr) Boisson et aliment antioxydants et vitaminés utilisant un aptamère, et leur procédé de production
Kauser et al. In vitro antioxidant and cytotoxic potential of methanolic extracts of selected indigenous medicinal plants
CA3038495C (fr) Procede de prevention de l'oxydation d'un materiau antioxydant a l'aide d'un aptamere, materiau et utilisation de celui-ci
JP2004538381A (ja) ゆっくりと放出される天然物質を浸透させた美容術用およびアンチエイジングのストッキングあるいはパンティストッキングと、その製造方法
Htwe et al. Liposomes of probiotic's lyophilized cell free supernatant; a potential cosmeceutical product
CA2896348C (fr) Compositions pour soins de la peau comprenant de l'acide folique et de la catechine de gallate
Rahim et al. Antioxidant activity of alstonia Angustifolia ethanolic leaf extract
JP2016190823A (ja) 神経成長因子抑制剤
Das Nanocosmeceuticals: Innovation, Application, and Safety
Ermini et al. Copper nano-architecture topical cream for the accelerated recovery of burnt skin
KR101599907B1 (ko) 천연 원료 추출물을 포함하는 항산화제 및 이의 용도
RU2560839C1 (ru) Состав косметического средства геропротекторного действия
Koster et al. Biofield Energy Healing Based Herbomineral Formulation: An Emerging Frontier in Cosmetic Medicine
US20050031710A1 (en) Method of personal care and cosmetic product preparation and composition using human blood type
Joshi et al. Evaluation of antioxidant activity of some medicinal plants and their combination
Meagher et al. An in vitro study of biofield energy healing based herbomineral formulation for skin protection
Yepes-Molina et al. Nanoencapsulation of Pomegranate Extract to Increase Stability and Potential Dermatological Protection. Pharmaceutics 2021, 13, 271

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16901784

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22/02/2019)

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22.02.2019)

122 Ep: pct application non-entry in european phase

Ref document number: 16901784

Country of ref document: EP

Kind code of ref document: A1